Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer.
about
Myoepithelial cells: good fences make good neighborsSignificance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinomaUrokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivoReversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodiesN-nitroso-N-ethylurea activates DNA damage surveillance pathways and induces transformation in mammalian cells.Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinomaIn situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontologyTissue architecture and breast cancer: the role of extracellular matrix and steroid hormonesThe importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay.Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells.Tissue architecture: the ultimate regulator of epithelial function?E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cellsIsolation and functional characterization of murine prostate stem cells.Involvement of alpha6beta4 integrin in the mechanisms that regulate breast cancer progression.The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in miceDistribution of integrin cell adhesion molecules in endometrial cancer.Adhesion systems in normal breast and in invasive breast carcinoma.Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells.Clinical significance of the integrin α6β4 in human malignancies.Down-regulation of laminin-5 in breast carcinoma cells.The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression.Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney.Structural centrosome aberrations favor proliferation by abrogating microtubule-dependent tissue integrity of breast epithelial mammospheresDifferentiation and cancer in the mammary gland: shedding light on an old dichotomy.Targeted RGD nanoparticles for highly sensitive in vivo integrin receptor imaging.Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion.Functional elucidation and methylation-mediated downregulation of ITGA5 gene in breast cancer cell line MDA-MB-468.Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivoIntegrin alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes.Analyzing the metastatic phenotype.Characterization of tumorigenic sub-lines from a poorly tumorigenic human colon-adenocarcinoma cell line.Variants of integrin beta 4 subunit in human endometrial adenocarcinoma cells: mediators of ECM-induced differentiation?The integrin alpha 6 beta 4 and the biology of carcinoma.Polarization of the alpha 6 beta 4 integrin in ovarian carcinomas.Cloning and characterization of the human beta4-integrin gene promoter and enhancers.Control of type II transforming growth factor-beta receptor expression by integrin ligation.Loss of alpha 6 and beta 4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas.Alpha6beta1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.sp2 -Iminosugar α-glucosidase inhibitor 1-C-octyl-2-oxa-3-oxocastanospermine specifically affected breast cancer cell migration through Stim1, β1-integrin, and FAK signaling pathways.
P2860
Q24813615-49459327-8EAE-45FE-B29D-A9F52DEFD63CQ28140971-77BF18E4-33D6-40B3-9F62-C7C10B1346FDQ28350698-DF3D5D00-4E53-4AC8-A872-3DE2DE896817Q29614313-9A9F3202-1FD3-4CE5-8987-FA74AE09B739Q30413046-FD822042-8818-4689-A4B7-2DCB4C024156Q33667939-F5F4D60D-3A85-4865-B458-9DE24DC91743Q33672680-B7F8F832-61F9-4C0E-B1F2-12C256472DDAQ33974007-A20A79B5-7FFD-49BB-AFDA-E0665D9CB4E9Q34103339-D0DB2470-6D48-4950-A429-1FE6A6CAFF35Q34103456-81DEE46C-83B0-4F6D-91E1-2458B3DE6D97Q35212052-FB2DA4A3-0662-47DF-A417-98ED5363FE6CQ35228257-7452FE72-BDA3-4B61-846E-77CD05713DA3Q35250689-E0B674FD-730A-4481-8EA8-96BC747DAEB5Q35749387-F45EE929-BBA3-46DB-9B4D-998803543E78Q35764011-672F8576-815C-4F00-99F4-A5FF6172CF1AQ35794894-13EC7740-8B70-469B-9B7A-1D49F48D438EQ35794930-C940D91B-6A91-4D54-BB8A-B77B071B4D71Q35796514-FF502509-072C-44E5-9DED-37B23DF1DDE9Q36010634-E991C431-B3F1-449E-9B78-758DA22F8965Q36438250-BC2D0E52-9B04-4984-9844-BDF568359E6BQ36468996-5AE2A003-8C2C-4064-AB55-27C245D6938DQ36648734-FDF4D0EE-EF98-4B49-923A-5334547842BBQ36970336-03599AE8-17AF-4D0B-9C07-AC588F937F88Q37401876-0F812BAB-3726-4125-B998-C538961CCCA5Q39394622-C3AC1293-10E0-4F29-BBB6-6BF25EA3F27CQ39588142-D1E25F07-7762-40AD-B49E-B181C160168DQ39690514-62C4F913-2A63-4E1F-8F30-143A930DD30DQ39795407-A417AE06-6E13-4528-9089-088D9A17EF1AQ39832889-1FE6A3B9-8756-4D3C-9C5D-3A2FD7DB7112Q40484728-A5684C2B-8C4B-44D7-AADB-EAE2B40F41A9Q40560412-9BAB79E8-0CAD-4EF1-B900-2B25EB4E93B6Q41168958-05C372DE-065F-4F55-850D-0CD8C42AA340Q41242058-C92464DE-B431-44B2-9863-34691633B4C0Q41481808-C09EBE1E-A6EA-4AEB-B8E8-FDD0FB4546DEQ41553993-FE90EC37-026D-4010-8838-D6A3073E8781Q42464762-9706ABF6-6784-4FE0-B551-FD49972B8609Q42470931-0AFA5D6C-0920-4A1A-AEFD-FC18B137ED84Q42504103-BCE78D04-14A3-46FC-A750-22E2363C5A06Q44313514-85B69749-556A-4DA2-AC86-CAA44ECA04B6Q46719191-2802726C-FE27-448F-867B-8A4DEA5FC358
P2860
Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Changes in expression of alpha ...... and metastatic breast cancer.
@ast
Changes in expression of alpha ...... and metastatic breast cancer.
@en
type
label
Changes in expression of alpha ...... and metastatic breast cancer.
@ast
Changes in expression of alpha ...... and metastatic breast cancer.
@en
prefLabel
Changes in expression of alpha ...... and metastatic breast cancer.
@ast
Changes in expression of alpha ...... and metastatic breast cancer.
@en
P2093
P2860
P356
P1476
Changes in expression of alpha ...... and metastatic breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1992.263
P407
P577
1992-08-01T00:00:00Z